Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07526194
PHASE1

A Study in Healthy Men to Test How Well Different Doses of BI 3821001 Are Tolerated

Sponsor: Boehringer Ingelheim

View on ClinicalTrials.gov

Summary

The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 3821001 in healthy male trial participants.

Official title: A Phase I Single-blind, Randomised, Placebo-controlled, Parallel Group Design Trial to Investigate the Safety, Tolerability and Pharmacokinetics of Single Rising Doses of BI 3821001 Administered to Healthy Trial Participants

Key Details

Gender

MALE

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

72

Start Date

2026-04-22

Completion Date

2026-10-02

Last Updated

2026-04-13

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

BI 3821001

BI 3821001

DRUG

Placebo

Placebo

Locations (1)

CRS Clinical Research Services Berlin GmbH

Berlin, Germany